Who should consider speaking to a doctor?

There is no worldwide eligibility rule for prostate cancer screening. Recommendations vary by country, age, personal risk and whether you already have symptoms.

Anyone with a prostate who develops concerning symptoms should seek medical advice rather than relying on screening eligibility rules. Screening refers to testing people without symptoms; investigating symptoms is a different process.

Possible signs of prostate cancer include changes in urination, blood in urine or semen, erectile difficulties and, in more advanced disease, symptoms such as persistent back pain or unexplained weight loss. These symptoms have many possible causes.

Factors that can increase risk

According to the NHS information on prostate cancer risk, risk increases with age and is higher in some groups. Factors to tell your healthcare professional about include:

  • Increasing age
  • A family history of prostate cancer
  • Black African or African Caribbean background
  • Certain inherited genetic changes, including BRCA2
  • A close family history of some breast, ovarian or pancreatic cancers, which can sometimes indicate inherited genetic risk

Having a risk factor does not mean you have or will develop prostate cancer.

Screening eligibility differs internationally

In the United States, the CDC prostate cancer screening guidance reports the US Preventive Services Task Force recommendation that men aged 55–69 make an individual decision about PSA screening after discussing potential benefits and harms with a clinician. Routine PSA screening is not recommended by that body for men aged 70 and older.

The UK does not operate a national population screening programme that automatically invites all men for prostate cancer screening. The NHS PSA guidance explains when and why PSA testing may be considered.

Australia also does not treat PSA testing as a universal population-screening programme. The Australian Government's prostate cancer screening information advises people considering testing to discuss its potential benefits and harms with their doctor.

Rules and clinical guidance can change, so use your country's current health authority guidance rather than assuming another country's age thresholds apply to you.

For informational purposes only. You may see ads on this content.

The Rainbow Hub

© 2026 The Rainbow Hub

Disclaimer

This is an independent, informational website. We are not affiliated with, endorsed by, or sponsored by any company, brand, or organization mentioned in our articles. All brand names and trademarks referenced belong to their respective owners and are used here for informational purposes only.

Content on this site is provided for general informational purposes only and should not be considered financial, medical, legal, or other professional advice. It is not a substitute for guidance from a qualified professional. Please consult an appropriate licensed professional before making any decisions. Program details, pricing, and eligibility may change and should be independently verified before you act on them.

Recommendation buttons use rewarded advertising. Completing an available ad opens the selected guide. If no ad is available, access continues.

Recommended Guide

Recommended guides